SUBJECT MATTER. In accordance with the terms and conditions laid down in this agreement, MIBGAS will provide the Market Participant with the services required for it to meet its reporting obligations included in Regulation (EU) No. 1227/2011 of the European Parliament and of the Council on wholesale energy market integrity and transparency (REMIT), regarding gas market transactions managed by MIBGAS.
SUBJECT MATTER. In accordance with the terms and conditions laid down in this agreement, MIBGAS Derivatives will provide the Market Participant with the services required for downloading the data of the accepted orders and transactions executed in the Orgainsed Gas Market in the valid format for reporting them to ACER and complying with the REMIT regulations. para el reporte a ACER en cumplimiento con la normativa REMIT.
SUBJECT MATTER. By means of this agreement, the Site provides authorization for the Clinical Trial referred to in the appendices of this agreement to be conducted in its facilities. It will be personally supervised, directed, and conducted by the Principal Investigator to whom the research tasks have been expressly delegated. Por otra parte, el Ensayo se realiza con un número estimado de ……… sujetos participantes y en un plazo máximo estimado de …………………..meses, tal y como se detalla en el Protocolo, pudiendo modificarse dicho número y plazo cuando se estime necesario, previa aprobación del correspondiente presupuesto. Cualquier desviación sobre esta cantidad, será comunicada por el/la Promotor/a al CEIm correspondiente. Furthermore, the Trial will be conducted with an estimated number of ……… participating subjects and within a maximum estimated period of …………………..months, as defined in the Protocol. The number of subjects and the period may be modified when deemed necessary, subject to prior approval of the corresponding budget. The Sponsor shall report any deviations from this amount to the corresponding ECRmp. El/La Promotor/a del ensayo se reserva el derecho de interrumpir la inclusión de pacientes en cualquiera de los siguientes casos; The trial Sponsor reserves the right to discontinue the enrollment of patients in any of the following cases: si el/la Investigador/a Principal no incluye el número pactado de pacientes durante el período de tiempo designado If the Principal Investigator fails to enroll the agreed number of patients within the established time frame. si se alcanza el número total de pacientes que tienen que incluirse en el ensayo por los diferentes investigadores que participan en el mismo cuando se trate de un ensayo multicéntrico. If the total number of patients to be enrolled in the trial is reached by the various investigators participating therein in the case of multisite trials.
SUBJECT MATTER. By means of this agreement, the Site provides authorization for the Observational Study with medicinal products referred to in the appendices of this agreement to be conducted in its facilities. It will be personally supervised, directed, and conducted by the Principal Investigator to whom the research tasks have been expressly delegated. Por otra parte, el Estudio se realiza con un número estimado de ……… sujetos participantes y en un plazo máximo estimado de …………………..meses, tal y como se detalla en el Protocolo, pudiendo modificarse dicho número y plazo cuando se estime necesario, previa aprobación del correspondiente presupuesto. Cualquier desviación sobre esta cantidad, será comunicada por el/la Promotor/a al CEIm y a la dirección de centro correspondiente. Furthermore, the Study will be conducted with an estimated number of ……… participating subjects and within a maximum estimated period of …………………..months, as defined in the Protocol. The number of subjects and the period may be modified when deemed necessary, subject to prior approval of the corresponding budget. The Sponsor shall report any deviations from this amount to the corresponding ECRmp and Site management.